Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma.
- Author:
Wen ZHENG
;
Jun ZHU
;
Yan XIE
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Aged;
Agranulocytosis;
chemically induced;
Antineoplastic Combined Chemotherapy Protocols;
adverse effects;
therapeutic use;
Cisplatin;
administration & dosage;
adverse effects;
Cyclophosphamide;
administration & dosage;
adverse effects;
Doxorubicin;
administration & dosage;
adverse effects;
Etoposide;
administration & dosage;
adverse effects;
Female;
Follow-Up Studies;
Humans;
Lymphoma, T-Cell, Peripheral;
drug therapy;
Male;
Middle Aged;
Nausea;
chemically induced;
Prednisone;
administration & dosage;
adverse effects;
Remission Induction;
Vincristine;
administration & dosage;
adverse effects;
Young Adult
- From:Chinese Journal of Oncology
2008;30(11):875-876
- CountryChina
- Language:Chinese
